Partner
Eurobio Scientific UK Limited
DiaSys lists Eurobio Scientific UK Limited in its distributor directory for Ireland.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Partner
DiaSys lists Eurobio Scientific UK Limited in its distributor directory for Ireland.
Partner
PathoNostics lists Eurolab Lambda a.s. in its distributor directory for Slovakia.
Partner
TOYOBO lists EUROMEDEX in its distributor directory for France.
Indicators
A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05)
Partner
PTS Diagnostics lists Exelle Medic in its distributor directory for Morocco.
Partner
PathoNostics lists ExoMedica in its distributor directory for Baltic States.
Glossary Term
The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.
Glossary Term
An Exonuclease is a hydrolase (nuclease) that specifically catalyzes the hydrolysis of terminal phosphodiester bonds of deoxyribonucleotide or ribonucleotide chains, releasing mononucleotides.
Indicators
This gene plays a role in chromatin remodeling and transcriptional regulation.
Partner
Pillar Biosciences lists F&S Scientific Ltd in its distributor directory for Kenya.
Indicators
An abnormality that refers to mutation of factor V Leiden, which is a variant of human factor V. It results in thrombophilia, deep vein thrombosis, and a slightly increased risk of miscarriage.
Glossary Term
A statistical method used for multiple testing corrections to control the expected proportion of false positives (Type I error) among rejected tests or hypotheses. It is less stringent than other multiple testing corrections and thereby, will allow a percentage of false positives.